Two years after vaccine-associated myocarditis: what a long-term Danish study really shows
A critical look at symptoms, heart function, and scientific blind spots
A new long-term Danish study, published in the European Heart Journal, provides the first systematic data on patients who developed myocarditis after mRNA vaccination. The results contradict the long-held belief that the condition is almost always mild and fully reversible.
A third will get sick – years after vaccination
Of the 46 identified cases, 16 patients participated in the follow-up. Despite the small number, the pattern is clear:
- 31% still suffer from fatigue
- 31% have heart palpitations
- 25% experience chest pain during exertion
This means that more than one-third of people still have symptoms two to three years after the acute event – a clear contradiction to the public’s early portrayal of “mild vaccine-induced myocarditis.”
Biomarkers normal – heart function not
Although troponin, CRP, ECG, and lung ultrasound normalized, one central problem remains:
- Global longitudinal stress (GLS) only −12% (instead of the usual ~ −18%)
- Only 69% achieve LVEF ≥ 50%
- Diastolic function remains impaired in 12% of cases.
This suggests that the heart does not fully recover, even if laboratory results suggest otherwise. The discrepancy between biochemical and clinical recovery is a central concern of this study.
Why symptoms persist – without abnormal lab results
The study does not provide a mechanistic explanation, but possible causes include:
- Residual fibrosis (visible only with MRI – not performed)
- Autonomic dysregulation
- Microvascular dysfunction
- Subclinical chronic inflammation
This makes it clear: the pathology is more complex than previously depicted.
Methodological weaknesses – and why they tend to underestimate risks
- Only 16/46 participated → selection bias is possible; actual rate of persistent symptoms may be higher.
- Cardiac MRI is not performed → structural damage remains undetected.
- Stress diagnostics are not performed → many symptoms only appear in everyday life under stress.
- There is no healthy control group.
Thus, the study is valuable but incomplete.
Weak public risk communication
For years the message was:
- “Mostly mild”
- “Fully reversible”
- “Harmless”
The Danish results clearly contradict this rhetoric:
- 1/3 still have symptoms
- Heart function is still impaired
- The long-term risks are unclear.
- Biomarkers do not reliably reflect the condition of the heart.
These data call for an honest reassessment of risk-benefit communication.
Summary: Vaccine-induced myocarditis is medically and politically underappreciated.
The study shows:
- Significant long-term consequences for a significant proportion of those affected
- Measurable functional impairment despite “healthy-looking” laboratory results
- Inadequate diagnostics (lack of MRI and stress tests)
- Urgent need for long-term follow-up care and better research
